4.2 Review

Treating pediatric migraine: an expert opinion

期刊

EXPERT OPINION ON PHARMACOTHERAPY
卷 13, 期 7, 页码 959-966

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1517/14656566.2012.677434

关键词

acute headache treatment; non-pharmacological treatment; nutraceuticals in pediatrics; pediatric headache; pediatric migraine; prophylactic headache treatment

资金

  1. American Headache Society
  2. Endo Pharmaceutical
  3. Tishcon
  4. USB Pharma
  5. GlaxoSmithKline

向作者/读者索取更多资源

Introduction: Headaches are common in children and adolescents and migraine affects almost 8% of this population. As revisions are made to the ICHD-II criteria to include additional characteristics of pediatric migraine, the diagnosis of migraine is expected to increase. Therefore, it is important to understand and apply successful treatment in acute migraine. Patients and families should be educated about the options for migraine treatment that includes both pharmacologic and conservative behavioral techniques in managing headaches. Areas covered: This review examines the studies that have been performed in pediatric patients, in addition to exploring the treatment options commonly used in pediatrics and adolescents for migraine and their rationale for use. Expert opinion: For the acute treatment of migraine, we recommend the use of ibuprofen or acetaminophen for mild, moderate or severe headache. For moderate to severe headache, or for headaches that fail to respond to over-the-counter medications, we recommend the use of a triptan or combination NSAID/triptan therapy. For preventative treament of migraine, cyproheptadine should be reserved for younger children unable to swallow tablets while amitriptyline is preferred due to its once daily dosing and minimal side effects. Topiramate and divalproate are considerable options depending on patient co-morbid profile and preference.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据